Q1 FY27 results: Zenotech swings to Rs 46 lakh loss vs profit YoY

Pat NegativeEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.2%Reaction day

₹45.00

prior close

₹45.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-1.0% vs market

Pharmaceuticals peers, median of 165sector-0.8%-1.4% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+2.1

15m

+0.0

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.2-1.3-1.0-0.8-1.4

Next day

-2.1-0.8-1.3+0.3-2.4

-0.3-1.4+1.0-0.7+0.4

-0.0-0.3+0.3-0.3+0.3

-1.6+1.0-2.7+0.3-1.9

-3.2+1.5-4.6+0.7-3.9

-1.0+3.1-4.1+0.3-1.2

15d

+5.8+4.1+1.7+1.0+4.8

+4.0+4.8-0.7+1.4+2.6

-6.7+3.1-9.8+2.4-9.1

-16.0-3.6-12.4-2.0-14.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenotech Labs Q1 FY27 (quarter ended June 30, 2026): Revenue from operations grew 11 percent YoY to Rs 959.64 lakh. But total expenses surged 30 percent YoY to Rs 1,164.86 lakh, driven by higher employee costs (up 39 percent) and other expenses (up 32 percent). The company swung to a loss after tax of Rs 45.55 lakh versus a profit of Rs 98.96 lakh in Q1 FY26. EPS was negative 0.07. Auditor GSK A and Co gave an unmodified review. 37th AGM set for September 25, 2026.

Likely market impact

Margins compressed sharply as costs grew much faster than revenue, pushing the company into a quarterly loss versus a profit a year ago.